0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
RSS Email Alerts
Please Wait... Processing your request... Please Wait.

Journal Articles

in Targeted and Immune Therapy

Sign in

Purchase Options

• Subscribe to the journal

A free personal account provides

• Free current issues on The JAMA Network Reader
• Free quizzes on The JAMA Network Challenge
• Commenting and personalized alerts
From The JAMA Network
JAMA Ophthalmology
Original Investigation  | 
Repeated Intravitreous Ranibizumab Injections for Diabetic Macular Edema and the Risk of Sustained Elevation of Intraocular Pressure or the Need for Ocular Hypotensive Treatment
Susan B. Bressler, MD; Talat Almukhtar, MBChB; Anjali Bhorade, MD; et al.
JAMA
Editorial  | 
Precision Medicine to Improve the Risk and Benefit of Cancer Care:  Genetic Factors in Vincristine-Related Neuropathy
Howard L. McLeod, PharmD
JAMA
Viewpoint  | 
Genomic Engineering and the Future of Medicine
Jennifer A. Doudna, PhD
JAMA Oncology
Observation  | 
Alpha Emitter Radium 223 in High-Risk Osteosarcoma:  First Clinical Evidence of Response and Blood-Brain Barrier Penetration
Vivek Subbiah, MD; Pete Anderson, MD, PhD; Eric Rohren, MD, PhD